Back to ACRS
WELLINGTON MANAGEMENT GROUP LLP → ACRS
WELLINGTON MANAGEMENT GROUP LLP ACRS Position History
Aclaris Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$1.3M
Q3 2026
Peak value
$1.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $227K |
| Q4 2025 | $36K |
| Q4 2025 | $533K |
| Q1 2026 | $295K |
| Q1 2026 | $46K |
| Q1 2026 | $623K |
| Q2 2026 | $448K |
| Q2 2026 | $59K |
| Q2 2026 | $908K |
| Q3 2026 | $798K |
| Q3 2026 | $128K |
| Q3 2026 | $1.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.3M | 251.0K | — | — |
| Q3 2026 | $128K | 24.3K | — | — |
| Q3 2026 | $798K | 151.6K | — | — |
| Q2 2026 | $908K | 171.6K | — | — |
| Q2 2026 | $59K | 11.1K | — | — |
| Q2 2026 | $448K | 84.7K | — | — |
| Q1 2026 | $623K | 166.2K | — | — |
| Q1 2026 | $46K | 12.2K | — | — |
| Q1 2026 | $295K | 78.8K | — | — |
| Q4 2025 | $533K | 177.1K | — | — |
| Q4 2025 | $36K | 11.8K | — | — |
| Q4 2025 | $227K | 75.4K | — | — |